SGPP2 and central nervous system cancer: Another recent study from Abuhusain et al. demonstrated that an altered S1P/ceramide balance with reduced C18 ceramide and elevated S1P as well as increased SphK1 and decreased SGPP2 expression may be an important feature of human gliomas [17].